NIH awards Boragen grant for antimalarial drug discovery
Boron-based discovery platform firm Boragen has received a phase I Small Business Innovation Research grant from the U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to support antimalarial drug discovery. Read More
FibroGenesis cell therapy product could treat COVID-19 fibrosis
FibroGenesis has released new preclinical data regarding its PneumoBlast cell therapy product for reducing lung injury associated with COVID-19 in preparation for an investigational new drug submission to the U.S. Food and Drug Administration. Read More
AstraZeneca, Oxford release early clinical data for COVID-19 vaccine
AstraZeneca, in collaboration with Oxford University, has released positive preliminary data about immune responses generated by the SARS-CoV-2 viral vector vaccine candidate AZD1222. Read More
Kedrion, Columbia partner on IgG COVID-19 therapy
Italian biopharmaceutical company Kedrion Biopharma and Columbia University's Irving Medical Center have entered into a partnership to develop a new immunoglobulin G (IgG) therapy for COVID-19. Read More
Beacon releases new clinical trial database
Beacon Targeted Therapies has released a new clinical trial and drug database called Beacon Oncolytic Viruses. Read More
Sorrento plans phase II trial for COVID-19 treatment
Sorrento Therapeutics received clearance from the U.S. Food and Drug Administration to initiate a phase II clinical trial evaluating abivertinib for treatment of moderate and severe COVID-19 patients. Read More
Pfizer, BioNTech release clinical data for COVID-19 vaccine candidate
Pfizer and BioNTech have released initial data from an ongoing phase I/II clinical trial for the COVID-19 messenger RNA-based vaccine candidate BNT162b1. Read More
Thermo Fisher expands COVID-19 therapies, vaccines
Thermo Fisher Scientific is expanding the development and production of COVID-19 vaccines, therapies, and additional treatments. Read More
New guidance released on genetic testing for dyslipidemia patients
The National Lipid Association has released an official scientific statement on the use of genetic testing in the diagnosis and management of patients with dyslipidemia. Read More
Fox Chase creates AI program for virtual drug screening
Fox Chase Cancer Center researchers have developed a new artificial intelligence (AI) program that could make virtual screening for cancer drugs more effective. Their findings were published July 15 in the Proceedings of the National Academy of Sciences. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
